Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
17,82 USD | -1,05% | +0,06% | -1,60% |
25/06 | Takeda's geneesmiddel tegen kanker krijgt goedkeuring van Europese Commissie | MT |
24/06 | Hutchmed China stelt vast dat Takeda EU-goedkeuring heeft gekregen voor Fruzaqla | AN |
Vakgebied
Aantal werknemers: 1 988
Verkoop per activiteit
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Oncology/Immunology - Research and Development
43,5
%
| 307 | 9,2 % | 2 853 | 43,5 % | +829,49% |
Other Ventures
36,9
%
| 2 056 | 61,6 % | 2 422 | 36,9 % | +17,81% |
Oncology/Immunology - Marketed Products
19,6
%
| 976 | 29,2 % | 1 285 | 19,6 % | +31,68% |
Verkoop per regio
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
57,9
%
| 3 339 | 100,0 % | 3 796 | 57,9 % | +13,69% |
United States and Others
42,1
%
| 0 | 0,0 % | 2 764 | 42,1 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wei Guo Su
CEO | Chief Executive Officer | 66 | 01-01-05 |
Chig Fung Cheng
DFI | Director of Finance/CFO | 57 | 01-07-08 |
Michael Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-01-22 |
Karen Atkin
COO | Chief Operating Officer | 58 | 01-01-21 |
Edith Shih
BRD | Director/Board Member | 71 | 01-01-00 |
Mark Lee
IRO | Public Communications Contact | 46 | - |
Selina Zhang
HRO | Human Resources Officer | - | 01-03-22 |
Yiling Cui
LAW | General Counsel | - | - |
Charles Nixon
LAW | General Counsel | 54 | 01-01-06 |
May Wang
PRN | Corporate Officer/Principal | 60 | 01-01-10 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Graeme Jack
BRD | Director/Board Member | 73 | 01-03-17 |
Dan Eldar
CHM | Chairman | 70 | 01-08-16 |
Edith Shih
BRD | Director/Board Member | 71 | 01-01-00 |
Paul Carter
BRD | Director/Board Member | 63 | 01-02-17 |
Chig Fung Cheng
DFI | Director of Finance/CFO | 57 | 01-07-08 |
Wei Guo Su
CEO | Chief Executive Officer | 66 | 01-01-05 |
Ling Yang
BRD | Director/Board Member | 44 | 13-07-23 |
Shu Kam Mok
BRD | Director/Board Member | 63 | 01-01-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 871 264 820 | 463 118 685 ( 53,15 %) | 0 | 53,15 % |
Bedrijfsgegevens
HUTCHMED (China) Ltd.
Cheung Kong Center 2 Queen's Road Central
, Hong Kong
+852 2121 8200
http://www.hutch-med.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,19% | 815 mld. | |
+47,26% | 654 mld. | |
-6,09% | 354 mld. | |
+21,92% | 337 mld. | |
+18,40% | 247 mld. | |
+3,64% | 229 mld. | |
+12,98% | 219 mld. | |
+10,86% | 171 mld. | |
-2,78% | 159 mld. |